Suchergebnisse - "Henipavirus"

PubPharm (277)

1

Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects : A Phase 1b Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Prime-Boost Regimen of Three Dose Levels of PHV02, a Nipah Virus Vaccine Candidate (rVSV-ΔG-EBOV GP-NiVG) in Healthy Adults

enthalten in: ClinicalTrials.gov | 2024

2

Infection and transmission of henipavirus in animals

enthalten in: Comparative immunology, microbiology and infectious diseases | 2024

von Qiu, X. | Wang, F. | Sha, A.

3

Structure and design of Langya virus glycoprotein antigens

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Wang, Z. | McCallum, M. | Yan, L. | +8

4

Guardians of Health : Navigating Nipah Virus Challenges in India

enthalten in: Infectious disorders drug targets | 2024

von Komal | Diksha | Patil, N. | +1

5

Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults : VRC 322/DMID 21-0016: A Phase I, Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults

enthalten in: ClinicalTrials.gov | 2024

6

Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes

enthalten in: Journal of virology | 2024

von Oguntuyo, K. | Haas, G. | Azarm, K. | +8

UpdateOf: bioRxiv. 2023 Nov 22;:. - PMID 38045373

7

A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease

enthalten in: Cell reports. Medicine | 2024

von Pastor, Y. | Reynard, O. | Iampietro, M. | +25

8

Potential for Person-to-Person Transmission of Henipaviruses : A Systematic Review of the Literature

enthalten in: The Journal of infectious diseases | 2024

von Hegde, S. | Lee, K. | Styczynski, A. | +4

9

A Phase 1 Study to Evaluate Safety & Immunogenicity of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects : A Phase 1 Randomized, Single Center, Double-Blind, Placebo-Controlled, Dose-Response and Open-Label or Single Blind Booster Study to Evaluate the Safety and Immunogenicity of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

enthalten in: ClinicalTrials.gov | 2024

10

A comprehensive review of Langya virus and framework for future zoonotic disease control

enthalten in: Reviews in medical virology | 2024

von Thien, D. | Tran, H. | Uyen, N. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]